Effectiveness and Safety of Using Prontosan to Treat Bacterial Biofilm
NCT06185465 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2024-02-23
Summary
The goal of this prospective, multi-center, randomized, parallel-controlled, open-label clinical study is to evaluate the effectiveness and safety of Prontosan wound irrigation solution comparing with Normal Saline on the removal of wound bacterial biofilm through observing the morphological characteristics and development of bacterial biofilm in chronic wound patients with secondary infections. The main questions it aims to answer are:
* Difference in scoring the positive rate of bacterial biofilm before the first treatment and on the 7th day of treatment in Group A and Group B
* Difference in scoring the positive rate of bacterial biofilm before the first treatment and on the 3rd day of treatment in Group A and Group B .
* Positive detection rate of bacterial biofilm in group and group B before the first treatment, and on the 3rd and 7th day of treatment, and difference of the positive detection rate of biofilm among the two groups.
* 4-phase typing of bacterial biofilm detected in Group A, Group B and Group C before the first treatment, and on the 3rd and 7th day of treatment, and the proportion difference of 4-phase typing of biofilm among the two groups.
* Wound healing rate
* Skin Infection Rating Scale (SIRS) score.
* Distribution of inflammatory cells on the wound.
* Detection rate of bacteria/drug-resistant bacteria on the wound and their correlation with the detection rate of bacterial biofilm.
Participants will be randomized to experimental group or Control group, Prontosan Wound Irrigation Solution or normal saline will be extracted with syringe (Dosage 1-2ml/cm2), and the wound is rinsed 1 cm from the wound. Then, Prontosan wound irrigation solution or normal saline is used to saturate the gauze, and the gauze is applied to the wound for 15 minutes. After removing the gauze, cover it with oil gauze, then cover it with 8 layers of gauze and wrap it with a bandage.
Conditions
- Irrigation Solution
- Chronic Wound
- Pressure Injury
- Diabetic Foot Ulcer
- Burns
Interventions
- DEVICE
-
Prontosan Wound Irrigation Solution
After debridement surgery, the test group is selected according to the randomization number of enrollment. For experimental group, Prontosan Wound Irrigation Solution is extracted with syringe (Dosage 1-2ml/cm2), and the wound is rinsed 1 cm from the wound. Then, Prontosan wound irrigation solution is used to saturate the gauze, and the gauze is applied to the wound for 15 minutes. After removing the gauze, cover it with oil gauze, then cover it with 8 layers of gauze and wrap it with a bandage.
- DEVICE
-
Normal Saline
After debridement surgery, the test group is selected according to the randomization number of enrollment. For control group, normal saline is extracted with syringe (Dosage 1-2ml/cm2), and the wound is rinsed 1 cm from the wound. Then, normal saline is used to saturate the gauze, and the gauze is applied to the wound for 15 minutes. After removing the gauze, cover it with oil gauze, then cover it with 8 layers of gauze and wrap it with a bandage.
Sponsors & Collaborators
-
Shenzhen Second People's Hospital
collaborator OTHER -
Fujian Medical University Union Hospital
collaborator OTHER -
The First Hospital of Jilin University
lead OTHER
Principal Investigators
-
Jia'ao Yu, Professor · The First Hospital of Jilin University
-
Jun Wu, Professor · Shenzhen Second People's Hospital
-
Zhaohong Chen, Professor · Fujian Medical University Union Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-03
- Primary Completion
- 2024-02-21
- Completion
- 2025-02-28
Countries
- China
Study Locations
More Related Trials
-
Investigation of a Novel Wound Gel to Improve Wound Healing in Chronic Wounds
NCT03686904 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Activated Saline in Wound Treatment
NCT05924867 ·Status: UNKNOWN ·Phase: NA
-
Impact of Prontosan Wound Gel X on Surgical Site Infections in Cardiac Surgery
NCT07275307 ·Status: NOT_YET_RECRUITING
-
Comparing Outcomes for Prontosan Versus Normal Saline for Negative Pressure Wound Therapy With Instillation
NCT01939145 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot Study of the Provant Therapy System in Subjects With Diabetic Foot Ulcers
NCT00761176 ·Status: TERMINATED ·Phase: NA
-
Prospective, Randomized, Multi-Center Comparative Study on Topical Probiotics in Diabetic Foot Ulcers
NCT07008573 ·Status: COMPLETED
-
Treatment of Infected Surgical Wounds With Negative Pressure Topical Therapy and Instillation (With or Without Antiseptic) Versus no Instillation
NCT02500875 ·Status: UNKNOWN ·Phase: PHASE3
-
Prevention of Infection Using a Topical Gentamicin-Collagen Sponge in Diabetic Patients With An Uninfected Foot Ulcer
NCT00658957 ·Status: TERMINATED ·Phase: PHASE2
-
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02427802 ·Status: COMPLETED ·Phase: PHASE3
-
Macrophage Stimulating Factor in the Treatment of Diabetic Wounds
NCT06608303 ·Status: COMPLETED ·Phase: NA
-
PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
NCT03248466 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Nocardia Cell Wall Skeleton for the Treatment of Diabetic Foot Ulcer Wounds
NCT05368142 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
NCT02447172 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Preliminary Efficacy of PalinGen Flow Amniotic Tissue Allograft in Chronic Ulcers of the Lower Extremities
NCT04667416 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Pilot RCT of Veraflo With Prontosan vs VAC in Wounds Requiring Operative Debridement
NCT01867580 ·Status: COMPLETED ·Phase: NA
-
Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
NCT04689425 ·Status: UNKNOWN ·Phase: PHASE3
-
Use of Santyl Within an Accountable Care Organization
NCT02716519 ·Status: WITHDRAWN ·Phase: PHASE4
-
Use of AC5® Advanced Wound System in the Treatment of Diabetic Foot Ulcers
NCT06028386 ·Status: UNKNOWN ·Phase: NA
-
Treatment of PRP on Diabetes Wound
NCT02088268 ·Status: COMPLETED ·Phase: NA
-
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
NCT05169814 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Santyl vs. Sharp Debridement of Diabetic Foot Wounds
NCT01056198 ·Status: COMPLETED ·Phase: PHASE4
-
Wound Edge Changes Following Treatment With Santyl
NCT01197898 ·Status: COMPLETED ·Phase: PHASE4
-
Is Pressurized Irrigation an Effective Alternative to Swabbing for Wound Cleansing?
NCT01885273 ·Status: COMPLETED ·Phase: NA
-
Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM
NCT06565156 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Safety, and Performance of ConvaFoam™ Dressings in the Management of Indicated Chronic Wound Types.
NCT05632250 ·Status: COMPLETED ·Phase: NA